COOL Nordic Cargo Hub at Helsinki Airport

In 2018 Finnair Cargo opened one of the most sophisticated and modern air cargo terminals in the industry. Dedicated truck docks ensure that pharmaceuticals are handled correctly and stored at the right temperatures from the moment of arrival.

click on image

CEIV PHARMA CERTIFICATION

As the first airline in the world to be awarded IATA’s CEIV pharma certification it means that the correct handling, storage and transport of pharma is in Finnair Cargo’s DNA. Temperature sensors send live data to the Control Center and staff perform pharma checks on foot.

click on image

TEMPERATURE CONTROLLED FACILITIES

Three distinct temperature zones for pharma cover a total of 3,000 m². 25 temperature monitors send live data from the refrigerated, room-temperature and freezer zones and there is a strict process in the unlikely event of a temperature deviation.

click on image

ACTIVE AND PASSIVE CONTAINERS

Finnair Cargo offers active and passive containers for pharma customers. There is a specific acceptance process for active containers and dedicated staff who are trained in the checking, maintenance and handling of containers.

click on image

state of

the art 

In the Control Center, experts are at work day and night. Finnair Cargo’s COOL terminal uses the latest digital technologies and human expertise to make sure everything goes smoothly.

click on image

MAJOR GREEN MILESTONES

Finnair was the first airline in Europe to begin operating the next-generation fuel-efficient Airbus A350 aircraft. Pilots are able to adjust the temperature in the hold and shippers can use loggers to review temperatures.

click on image

GREEN AIR CARGO TERMINAL

Because Helsinki is uncongested, pharma leaves the COOL terminal for a flight just 30 minutes before departure. This guarantees that shipments are not adversely exposed to outside temperature variations.

click on image

Read more at: cargo.finnair.com

COOL Nordic Cargo Hub at Helsinki Airport

In 2018 Finnair Cargo opened one of the most sophisticated and modern air cargo terminals in the industry. Dedicated truck docks ensure that pharmaceuticals are handled correctly and stored at the right temperatures from the moment of arrival.

tap on image

CEIV PHARMA CERTIFI-CATION

As the first airline in the world to be awarded IATA’s CEIV pharma certification it means that the correct handling, storage and transport of pharma is in Finnair Cargo’s DNA. Temperature sensors send live data to the Control Center and staff perform pharma checks on foot.

tap on image

TEMPERA-TURE CONTROLLED FACILITIES

Three distinct temperature zones for pharma cover a total of 3,000 m². 25 temperature monitors send live data from the refrigerated, room-temperature and freezer zones and there is a strict process in the unlikely event of a temperature deviation.

tap on image

ACTIVE AND PASSIVE CONTAINERS

Finnair Cargo offers active and passive containers for pharma customers. There is a specific acceptance process for active containers and dedicated staff who are trained in the checking, maintenance and handling of containers.

tap on image

state of the art

In the Control Center, experts are at work day and night. Finnair Cargo’s COOL terminal uses the latest digital technologies and human expertise to make sure everything goes smoothly.

tap on image

MAJOR GREEN MILESTONES

Finnair was the first airline in Europe to begin operating the next-generation fuel-efficient Airbus A350 aircraft. Pilots are able to adjust the temperature in the hold and shippers can use loggers to review temperatures.

tap on image

GREEN AIR CARGO TERMINAL

Because Helsinki is uncongested, pharma leaves the COOL terminal for a flight just 30 minutes before departure. This guarantees that shipments are not adversely exposed to outside temperature variations.

tap on image

Read more at: cargo.finnair.com

Go to article: Home | The absence of antivenomGo to article: In this issueGo to article: Daiichi JitsugyoGo to article: ContentsGo to article: Capsugel Company InsightGo to article: CapsugelGo to article: NewsGo to article: Scandinavian Health Ltd.Go to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: The pharma industry briefingGo to article: TSS Company InsightGo to article: TSS ABGo to article: Action Medical Research: celebrating decades of discovery Go to article: Swiss WorldCargoGo to article: Gerteis Company InsightGo to article: GerteisGo to article: Moehs Iberica SLGo to article: Owen MumfordGo to article: How government policy has shaped China’s pharma phenomenonGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Novo NordiskGo to article: Snake venom in pharma; access to antivenom is a topic that needs attentionGo to article: Phoenix Group Company InsightGo to article: Phoenix Group Go to article: ME Logistic ServicesGo to article: Discussing drug policy reform with psychedelics campaigner Amanda FeildingGo to article: Finnair Cargo | Company InsightGo to article: Finnair CargoGo to article: Aseptic TechnologiesGo to article: False flags: are search engines benefiting rogue online pharmacies?Go to article: CBDepot Company InsightGo to article: CBDepotGo to article: Wilco Company Insight Go to article: WilcoGo to article: The Mighty: how patients and pharma align in the age of social media Go to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: MicronovaGo to article: Inside Italy’s pharmaceutical industry Go to article: KlingeGo to article: BEAGo to article: Erdmann Design SwitzerlandGo to article: Inside the UK’s first vaccines innovation centreGo to article: AralabGo to article: Applikon BiotechnologyGo to article: BaxterGo to article: NymiGo to article: Fostering closer collaboration between manufacturing & regulatory functionsGo to article: EmisphereGo to article: SephaGo to article: Contract Pharmaceuticals Limited CanadaGo to article: EventsGo to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: Next issueGo to article: PolpharmaGo to article: BioAdvice